A46 Erysipelas

✓ Billable ICD-10-CM 2026
Open A46 in Web App →

The ICD-10-CM code for Erysipelas is A46 (FY2026). It is a billable, claim-ready diagnosis code.

Classification

Section
A30-A49: Other bacterial diseases (A30-A49)
Category A46
1 code (1 billable)
FY2026 Status
Stable since FY2024

Also Known As

ICD-10-CM Alphabetic Index entries that lead to A46:

  • Erysipelas (gangrenous) (infantile) (newborn) (phlegmonous) (suppurative)
  • Erysipelas (gangrenous) (infantile) (newborn) (phlegmonous) (suppurative) › external ear
  • Arthritis, arthritic (acute) (chronic) (nonpyogenic) (subacute) › due to or associated with › erysipelas
  • Otitis (acute) › externa › in (due to) › erysipelas
Excludes1
Not coded here. These conditions should NOT be coded together with A46.
  • postpartum or puerperal erysipelas (O86.89)

U.S. Hospital Utilization

  • An estimated 5,295 U.S. inpatient stays in 2023 included A46 among the documented diagnoses.
  • 885 stays listed it as the principal diagnosis.

Source: National Inpatient Sample (NIS), Healthcare Cost and Utilization Project (HCUP), Agency for Healthcare Research and Quality, 2016–2023. National survey-weighted estimates.

Official Coding Guidelines

HIV Infections (TOC entry)

a. Human Immunodeficiency Virus (HIV) Infections .............................................................. 19

— ICD-10-CM Official Guidelines for Coding and Reporting, FY2026, Section I.C.1.a
Infectious agents causing diseases in other chapters (TOC)

b. Infectious agents as the cause of diseases classified to other chapters ................................. 22

— ICD-10-CM Official Guidelines for Coding and Reporting, FY2026, Section I.C.1.b

Source: CMS — ICD-10-CM Official Guidelines for Coding and Reporting, FY2026

References

Search all 70,000+ ICD-10-CM codes →
Reviewed by Prajwal Shrestha, CPC, CRC
Certified Professional Coder (CPC) and Certified Risk Adjustment Coder (CRC) · AAPC Member ID 01997614 · About · Editorial policy · Content last reviewed: 2025-10-01

Get HCC Mappings, Clinical Summaries, and More

Access premium features including HCC risk adjustment, FDA drug indications, AI coding assistant, and comprehensive clinical context.

Start Free Trial